Research of novel anticancer agents targeting arginase inhibition

Area of Science:

• Biochemistry
• Oncology
• Enzymology

Background:

• Arginase is a key metalloenzyme involved in L-arginine metabolism.
• It regulates critical pathways including polyamine biosynthesis, nitric oxide production, and T-cell immune responses, all implicated in cancer progression.
• These roles highlight arginase as a significant factor in both cancer development and control.

Purpose of the Study:

• To review the multifaceted role of arginase in various aspects of cancer development.
• To outline existing synthetic and natural inhibitors of arginase.
• To discuss the potential of arginase inhibitors as novel anticancer agents.

Main Methods:

• Literature review of studies on arginase and cancer.
• Identification and categorization of synthetic and natural arginase inhibitors.
• Analysis of the mechanisms of action for identified inhibitors.
• Evaluation of documented anticancer effects of these inhibitors.

Main Results:

• Arginase significantly influences cancer growth and immune evasion.
• Several synthetic and natural compounds demonstrate arginase inhibitory activity.
• Some of these inhibitors have exhibited direct anticancer effects in preclinical studies.
• The data supports arginase inhibition as a viable therapeutic strategy.

Conclusions:

• Arginase is a critical target for cancer intervention due to its role in cancer metabolism and immune modulation.
• Arginase inhibitors, both natural and synthetic, represent a promising avenue for novel cancer therapies.
• Further research into the clinical efficacy and safety of these inhibitors is warranted.